| Issue |
BIO Web Conf.
Volume 171, 2025
The Frontier in Sustainable Agromaritime and Environmental Development Conference (FiSAED 2024)
|
|
|---|---|---|
| Article Number | 03014 | |
| Number of page(s) | 14 | |
| Section | Environmental Health and Ecosystems | |
| DOI | https://doi.org/10.1051/bioconf/202517103014 | |
| Published online | 04 April 2025 | |
Imperata cylindrica L. Rhizome: Network pharmacology and molecular docking analysis of active ingredients and their mechanisms of action in treating acute kidney injury
1 Division of Pharmacy, School of Veterinary Medicine and Biomedical Sciences; IPB University, Bogor, Indonesia
2 Division of Pathology, School of Veterinary Medicine and Biomedical Sciences; IPB University, Bogor, Indonesia
3 Division of Biochemistry, Faculty of Mathematics and Natural Science; IPB University, Bogor, Indonesia
4 Laboratory of Animal Reproduction and Artificial Insemination, Department of Animal Production, Animal Husbandry Faculty, Padjajaran University, Bandung, Indonesia
* Corresponding author: rinipurwono@gmail.com
Acute kidney injury (AKI) is a significant health concern that can result in kidney impairment and failure. Imperata cylindrica L., a traditional medicinal plant, has shown potential in treating renal diseases, though its mechanisms in AKI remain unclear. This research integrated network pharmacology and molecular docking to analyze the active constituents of Imperata cylindrica rhizome in relation to AKI treatment. Pharmacological databases were used to identify the active compounds and their therapeutic targets, while Venny 2.1.0 was employed to determine the common targets shared with AKI-related drugs. A protein–protein interaction (PPI) network was generated to illustrate target associations. ShinyGo was utilized to perform Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. Molecular docking assessed the binding affinity and stability of active compounds with core targets. Key compounds, including 6-Methoxyflavone, Beta-Sitosterol, Bifendate, Luteolinidin, and Stigmasterol, were identified alongside 131 core targets. The docking results indicated strong binding interactions, suggesting therapeutic potential. These results offer valuable insight into the molecular mechanisms of I. cylindrica in AKI treatment, emphasizing the importance of further in vivo studies to validate its clinical effectiveness.
© The Authors, published by EDP Sciences, 2025
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.